Tevogen Bio Holdings Inc. (TVGN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on February 19, 2026, regarding a Special Meeting of Stockholders held by Tevogen Bio Holdings Inc. The company is an emerging growth company incorporated in Delaware with principal executive offices in Warren, New Jersey.
Key Financial Metrics
This filing is a current report regarding corporate governance and capital structure actions. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for these items.
Material Changes and Corporate Actions
Stockholders approved two significant proposals at the Special Meeting:
- 2024 Omnibus Incentive Plan Amendment: Approved an increase of 100,000,000 shares available for issuance under the 2024 Plan. Outstanding awards and reserved shares will be adjusted proportionally upon the effectiveness of the reverse stock split.
- Reverse Stock Split: Approved an amendment to the Certificate of Incorporation to effect a reverse stock split of common stock at a ratio between 1:25 and 1:85. The exact ratio and timing are at the sole discretion of the Board of Directors.
Voting Results
As of the record date (January 21, 2026), there were 201,522,282 shares outstanding. A total of 182,412,517 shares were present or represented at the meeting.
| Proposal | For | Against | Abstentions | Broker Non-Votes |
|---|---|---|---|---|
| 2024 Plan Amendment | 147,777,455 | 4,690,283 | 12,034 | 29,932,745 |
| Reverse Stock Split | 176,344,447 | 6,042,353 | 25,717 | - |
Outlook, Risks, and Management Commentary
The filing does not contain specific management commentary on future financial outlook, risks, or contingencies beyond the execution of the approved proposals. The reverse stock split is intended to be effected at a time and ratio determined by the Board, implying ongoing monitoring of the company's stock price and market conditions.
Key Facts for Investor Verification
- Verify the exact reverse stock split ratio and effective date once announced by the Board.
- Confirm the adjusted share count and impact on outstanding equity awards following the split.
- Review the full text of the Plan Amendment (Exhibit 10.1) for specific terms regarding the 100 million share increase.
- Monitor subsequent filings for financial updates, as this 8-K contains no operational or financial performance data.